Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $955,302 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $816,254 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2013 | $645,885 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2013 | $261,281 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2013 | $250,478 | | tax credit/rebate |
AAIPharma Services Corp. | Alcami | North Carolina | state | 2013 | $27,212 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2013 | $14,625 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2013 | $8,650 | | tax credit/rebate |
Mallinckrodt Enterprises Holdings, Inc. | Mallinckrodt | North Carolina | state | 2013 | $6,107 | | tax credit/rebate |
Novo Nordisk Biochem | Novo Holdings A/S | North Carolina | state | 1994 | $75,000 | | grant |
Biogen | Biogen | North Carolina | state | 1995 | $120,000 | | grant |
Merck & Co., Inc. | Merck | North Carolina | state | 1999 | $67,000 | | grant |
Merck & Co., Inc. | Merck | North Carolina | state | 2001 | $33,000 | | grant |
Embrex, Inc. | Pfizer | North Carolina | state | 2003 | $9,228 | | grant |
Abbott Laboratories | Abbott Laboratories | North Carolina | state | 2003 | $50,000 | | grant |
Embrex, Inc. | Pfizer | North Carolina | state | 2005 | $30,772 | | grant |
Novo Nordisk | Novo Holdings A/S | North Carolina | state | 2007 | $125,000 | | grant |
Sandoz (Eon) | Sandoz Group | North Carolina | state | 2008 | $150,000 | | grant |
Eisai, Inc. | Eisai | North Carolina | state | 2009 | $150,000 | | grant |
Novartis Vaccines & Diagnostics | Novartis | North Carolina | state | 2009 | $750,000 | | grant |
Novartis Vaccines & Diagnostics | Novartis | North Carolina | state | 2010 | $2,250,000 | | grant |
United Therapeutics | United Therapeutics | North Carolina | state | 2012 | $155,750 | | grant |
Novo Nordisk Pharmaceutical Industr | Novo Holdings A/S | North Carolina | state | 2012 | $288,000 | | grant |
Novo Nordisk Pharmaceutical Industr | Novo Holdings A/S | North Carolina | state | 2013 | $65,000 | | grant |
Hospira, Inc. | Pfizer | North Carolina | state | 2013 | $483,750 | | grant |
Novartis Vaccines & Diagnostics, Inc | Novartis | North Carolina | state | 2014 | $653,000 | | grant |
Novartis Vaccines & Diagnostics, Inc | Novartis | North Carolina | state | 2014 | $347,000 | | grant |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2013 | $4,097,786 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2013 | $687,362 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2013 | $231,735 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2013 | $167,753 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $147,230 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $72,693 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2013 | $63,148 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2013 | $44,364 | | tax credit/rebate |
Eon Labs, Inc. | Novartis | North Carolina | state | 2013 | $43,359 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2013 | $29,864 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2013 | $7,529 | | tax credit/rebate |
MYLAN TECHNOLOGIES | Viatris | Vermont | state | 2014 | $206,180 | | training reimbursement |
Durata Therapeutics, Inc. | AbbVie | Connecticut | state | 2013 | $8,000 | | tax credit/rebate |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | Florida | state | 2014 | $2,779,200 | | tax credit/rebate |
Lupin, Inc. | Lupin Limited | Florida | state | 2014 | $252,000 | | tax credit/rebate |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | Florida | state | 2014 | $3,500,000 | | grant |
Johnson and Johnson Vision Care, Inc. | Johnson & Johnson | Florida | state | 2014 | $1,300,000 | | grant |
Cambrex Charles City, Inc | Cambrex | Iowa | state | 2012 | $537,648 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2010 | $5,275,484 | | tax credit/rebate |
General Nutrition Corporation | Harbin Pharmaceutical Group | Indiana | state | 2014 | $200,000 | | training reimbursement |
Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals | Kentucky | state | 2014 | $25,000 | | training reimbursement |
Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals | Kentucky | state | 2015 | $2,500,000 | | tax credit/rebate |
BOEHRINGER INGELHEIM VETMEDICA, INC. | Eli Lilly | Missouri | state | 2014 | $273,219 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2014 | $3,476,438 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2014 | $645,884 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2014 | $185,492 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $97,337 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2014 | $59,897 | | tax credit/rebate |
AAIPharma Services Corp. | Alcami | North Carolina | state | 2014 | $19,526 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2014 | $29,864 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $162,504 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2014 | $218,428 | | tax credit/rebate |
C3I | Merck | New Hampshire | state | 2014 | $9,576 | | training reimbursement |
EMD Millipore | Merck KGaA (EMD) | New Hampshire | state | 2015 | $53,263 | | training reimbursement |
C3I | Merck | New Hampshire | state | 2015 | $5,908 | | training reimbursement |
Biovail Americas Corporation and subsidiaries | Bausch Health | New Jersey | state | 2013 | $39,502,500 | | tax credit/rebate |
Sandoz Inc. | Sandoz Group | New Jersey | state | 2014 | $9,180,000 | | tax credit/rebate |
ETHICON, INC. | Johnson & Johnson | Texas | state | 2002 | undisclosed | | enterprise zone |
ETHICON, INC. | Johnson & Johnson | Texas | state | 2002 | undisclosed | | enterprise zone |
ETHICON, INC. | Johnson & Johnson | Texas | state | 2003 | undisclosed | | enterprise zone |
ETHICON INC | Johnson & Johnson | Texas | state | 2002 | undisclosed | | enterprise zone |
PHARMAVITE LLC | Otsuka Pharmaceutical | California | state | 2014 | $17,618 | | training reimbursement |
BOEHRINGER INGELHEIM FREMONT, INC. | Boehringer Ingelheim | California | state | 2014 | $248,794 | | training reimbursement |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2014 | $344,534 | | training reimbursement |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2015 | $40,702 | | property tax abatement |
IDEXX LAB INC | IDEXX Laboratories | Maine | state | 2015 | $28,944 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2015 | $6,697 | | property tax abatement |
IDEXX PHARMACEUTICALS INC | IDEXX Laboratories | Maine | state | 2015 | $3,126 | | property tax abatement |
Zoetis, LLC | Zoetis | Nebraska | state | 2014 | undisclosed | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2015 | $6,700,000 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2015 | $9,000,000 | | tax credit/rebate |
Acorda Therapeutics | Acorda Therapeutics | New York | state | 2015 | $5,209,220 | | tax credit/rebate |
Par Pharmaceutical Companies, Inc. | Endo International | New York | state | 2015 | $2,500,000 | | tax credit/rebate |
Protein Sciences Corp | Sanofi | New York | state | 2015 | $2,000,000 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2015 | $10,200,000 | | tax credit/rebate |
Silarx Pharmaceuticals, Inc. | Lannett Co. | New York | state | 2015 | $952,757 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2014 | $253,035 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2014 | $143,193 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $126,863 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2014 | $117,680 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2014 | $57,885 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | North Carolina | state | 2014 | $13,840 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2014 | $11,365 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2014 | $8,340 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2014 | $5,969 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | North Carolina | state | 2014 | $5,583 | | tax credit/rebate |
Pozen, Inc. | Miravo Healthcare | North Carolina | state | 2014 | $5,426 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | North Carolina | state | 2014 | $1,644 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2014 | $6,118,950 | | tax credit/rebate |
GlaxoSmithKline, LLC (f/k/a SmithKline Beecham Corporation) | GlaxoSmithKline | Pennsylvania | state | 2014 | $3,353,317 | | tax credit/rebate |
Janssen Research & Development, LLC (f/k/a J&J Pharmaceutical Research & Development LLC) | Johnson & Johnson | Pennsylvania | state | 2014 | $2,207,905 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Pennsylvania | state | 2014 | $1,144,884 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2014 | $957,730 | | tax credit/rebate |
Shire US Holdings, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2014 | $914,646 | | tax credit/rebate |